Publication:
Target product profile for a diagnostic test to confirm leprosy in individuals with clinical signs and symptoms

dc.contributor.authorWorld Health Organization. Control of Neglected Tropical Diseases
dc.contributor.authorCruz, Israel
dc.date.accessioned2023-07-28T08:30:47Z
dc.date.available2023-07-28T08:30:47Z
dc.date.issued2023
dc.description.abstractLeprosy, is a chronic infectious disease caused by Mycobacterium leprae or, in some cases, by Mycobacterium lepromatosis. The bacteria is likely transmitted via tiny droplets (aerosols) from the nose and mouth during close and frequent contact with untreated cases. In some circumstances, skin-to-skin contact has also been implicated. Close and frequent contact increase the risk of contacts developing leprosy. Stigmatization and discrimination impede the life of an individual suffering from leprosy; overcoming them is an essential part of leprosy control. As with other neglected tropical diseases (NTDs), the occurrence of leprosy is often related to socioeconomic determinants of health. Despite the available treatment, more than 200 000 new leprosy patients were diagnosed globally in 2019, Early case detection is important to help contain the spread of infection and prevent disabilities.es_ES
dc.description.peerreviewedes_ES
dc.description.tableofcontents1. Epidemiology. 2. Public health response. 3. Available diagnostic tools. 4. WHO Diagnostic Technical Advisory Group for Neglected Tropical Diseases. 5. WHO Technical Advisory Group on Leprosy. 6. Purpose of the Target product profile (TPP). 7. Audiences engaged and external consultations to develop the diagnostic TPP.es_ES
dc.identifier.citationWorld Health Organization. (‎2023)‎. Target product profile for a diagnostic test to confirm leprosy in individuals with clinical signs and symptoms. World Health Organizationes_ES
dc.identifier.isbn978-92-4-007373-9es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/16326
dc.language.isoenges_ES
dc.publisherOrganización Mundial de la Salud (OMS)es_ES
dc.relation.publisherversionhttps://apps.who.int/iris/handle/10665/371647es_ES
dc.repisalud.centroISCIII::Escuela Nacional de Sanidades_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución-NoComercial-CompartirIgual 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.subjectLeprosyes_ES
dc.subjectDiagnostic testes_ES
dc.subjectClinical signses_ES
dc.subjectClinical symptomses_ES
dc.subjectTropical diseaseses_ES
dc.subjectMycobacterium lepraees_ES
dc.titleTarget product profile for a diagnostic test to confirm leprosy in individuals with clinical signs and symptomses_ES
dc.typetechnical reportes_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication4ca3b46e-2faa-4a7d-a134-d198c24d7475
relation.isAuthorOfPublication.latestForDiscovery4ca3b46e-2faa-4a7d-a134-d198c24d7475

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
TargetProductProfileDiagnosticTestT_2023.pdf
Size:
413.53 KB
Format:
Adobe Portable Document Format
Description: